Skip to main content
Search
Main content

Member Directory

Dr Nir Grossman

Group Leader

UK DRI at Imperial

Pioneering non-invasive neuromodulatory interventions to correct the abnormal brain activity in dementia

Learn more Dr Nir Grossman

Dr Emil Gustavsson

Group Leader

Interpreting genetic risk through transcriptomics to advance neurodegenerative therapies

Learn more Dr Emil Gustavsson

Dr Shlomi Haar

Emerging Leader

UK DRI Care Research & Technology at Imperial

Developing digital biomarkers to detect and monitor disease progression and symptom fluctuation in neurodegeneration

Learn more Dr Shlomi Haar